Label: JET ALERT REGULAR STRENGTH- caffeine tablet, coated
- NDC Code(s): 15579-201-09, 15579-201-20
- Packager: Bell Pharmaceuticals, Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Updated January 12, 2018
If you are a consumer or patient please visit this version.
- Active ingredient (in each tablet)
For occasional use only
When using this product
Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat. The recommended dose of this product contains about as much caffeine as a cup of coffee.
- Other information
- Inactive ingredients
- Package Labeling:
INGREDIENTS AND APPEARANCE
JET ALERT REGULAR STRENGTH
caffeine tablet, coated
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:15579-201 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE 100 mg Inactive Ingredients Ingredient Name Strength CALCIUM STEARATE (UNII: 776XM7047L) LACTOSE (UNII: J2B2A4N98G) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color white Score no score Shape ROUND Size 7mm Flavor Imprint Code 100 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:15579-201-20 1 in 1 CARTON 07/27/2016 1 120 in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:15579-201-09 1 in 1 CARTON 07/27/2016 2 30 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part340 07/27/2016 Labeler - Bell Pharmaceuticals, Inc (140653770)